Compare NU & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NU | SYK |
|---|---|---|
| Founded | 2013 | 1941 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7B | 127.0B |
| IPO Year | 2016 | 1994 |
| Metric | NU | SYK |
|---|---|---|
| Price | $15.45 | $338.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $17.84 | ★ $415.57 |
| AVG Volume (30 Days) | ★ 47.4M | 1.8M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 8.40 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $187.26 | $9.85 |
| Revenue Next Year | $20.60 | $8.36 |
| P/E Ratio | ★ $33.29 | $40.68 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $10.55 | $319.32 |
| 52 Week High | $18.98 | $404.87 |
| Indicator | NU | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 59.54 | 44.92 |
| Support Level | $15.39 | $328.23 |
| Resistance Level | $15.58 | $375.26 |
| Average True Range (ATR) | 0.44 | 7.00 |
| MACD | 0.22 | 2.28 |
| Stochastic Oscillator | 93.50 | 54.48 |
Nu Holdings Ltd provides digital banking services. It offers several financial services such as Credit cards, Personal accounts, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.